NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,316 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,316 Papers indexed
1,440 Papers AI scored
40,316 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-11 10:15 AM
1 Sensitive LC-MS/MS Method for Simultaneous Quantification of Alectinib and Its Major Metabolite M4 in Limited-Volume Human Plasma. Biomedical chromatography : BMC — Nov 11, 2026 2 Patient reimbursement in therapeutic cancer clinical trials: An 18-year multicenter experience. Cancer — Nov 11, 2026 3 Adulthood risk of non-communicable diseases associated with childhood and adolescent malnutrition in low- and middle-income countries: a systematic review of observational studies. BMJ global health — Nov 11, 2026 4 Parental night shift work and risk of breast cancer in daughters. Environmental research — Nov 11, 2026 5 Influence of diaphragm structure and function on the exercise ventilatory response in childhood cancer survivors and non-cancer controls. Respiratory medicine — Nov 11, 2026 6 Pregnancy and classic Hodgkin lymphoma: real world outcomes from a single center in Egypt. Current problems in cancer — Nov 11, 2026 7 Racial and Ethnic Differences in the Incidence of Langerhans Cell Histiocytosis Across the Age Spectrum. Blood advances — Nov 11, 2026 8 International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia. Blood — Nov 11, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40316 results
D
Revisiting Busulfan-Melphalan Sequencing in Paediatric Solid Tumours: A Pharmacokinetic Signal Beyond Conditioning Sequence.
PMID 42657648 Published: 2026-08-27 Ingested: 2026-08-29 09:15 AM Pediatric blood & cancer
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Intra-Axial Cerebral Schwannoma in a Child: A Case Report.
PMID 42646367 Published: 2026-07-29 Ingested: 2026-08-28 09:15 AM Neurology international
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Thyroid-stimulating hormone-secreting pituitary neuroendocrine tumor (TSH-PitNet) diagnosed during pregnancy and treated with a somatostatin analog.
PMID 42642161 Published: 2026-09-01 Ingested: 2026-08-27 09:15 AM Taiwanese journal of obstetrics & gynecology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Pilomatricoma in an Octogenarian: A Case Report of an Exceptional Late-Life Presentation.
PMID 42638289 Published: 2026-08-25 Ingested: 2026-08-27 09:15 AM The American journal of case reports
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial.
PMID 42631095 Published: 2026-08-21 Ingested: 2026-08-24 09:15 AM HemaSphere
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Case Report: Awake double-lumen tube intubation and intraoperative ventilation strategy conversion in an obese adolescent with a giant anterior mediastinal teratoma.
PMID 42630273 Published: 2026-08-07 Ingested: 2026-08-24 09:15 AM Frontiers in medicine
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Social vulnerability is not associated with reduced access to hematopoietic cell transplantation among referred pediatric patients with hematologic malignancies.
PMID 42629428 Published: 2026-08-21 Ingested: 2026-08-24 09:15 AM Bone marrow transplantation
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Correction to "Single-Cell RNA Sequencing Reveals the Heterogeneity in Differentiation Trajectory and Tumor Microenvironment Leading to More Aggressive Phenotypes of Papillary Thyroid Cancer in Children and Young Adult Patients".
PMID 42627634 Published: 2026-08-21 Ingested: 2026-08-23 09:15 AM Advanced science (Weinheim, Baden-Wurttemberg, Germany)
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Retrovesical Hybrid Benign Peripheral Nerve Sheath Tumor with a Heterozygous Germline NF2 Deletion in a 12-Year-Old Boy: A Case Report.
PMID 42623304 Published: 2026-08-20 Ingested: 2026-08-22 09:15 AM Fetal and pediatric pathology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Protocol fragility and molecular blindspots in pediatric central nervous system embryonal tumor regimens.
PMID 42622935 Published: 2026-08-20 Ingested: 2026-08-22 09:15 AM Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

Previous
Page 3033 of 3360
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic